$304.83
-1.30 (-0.425%)
At Close: Jun 03, 2026
The Global PCR System for Food Diagnostics Market will grow by USD 833.14 mn during 2020-2024
Will Bio-Rad (BIO) Gain on Rising Earnings Estimates?
04:20pm, Friday, 07'th Aug 2020
Bio-Rad (BIO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Are Robust Financials Driving The Recent Rally In Bio-Rad Laboratories, Inc.'s (NYSE:BIO) Stock?
02:23pm, Friday, 07'th Aug 2020
Most readers would already be aware that Bio-Rad Laboratories' (NYSE:BIO) stock increased significantly by 15% over...
The Global Antimicrobial Susceptibility Testing Market will grow by USD 900.75 mn during 2020-2024
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced that the United States Court of Appeals for the Federal Circuit to
Zurcher Kantonalbank Zurich Cantonalbank Grows Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)
07:04am, Tuesday, 04'th Aug 2020
Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) by 1.6% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned
Wells Fargo & Co Increases Bio-Rad Laboratories (NYSE:BIO) Price Target to $590.00
06:18am, Tuesday, 04'th Aug 2020
Bio-Rad Laboratories (NYSE:BIO) had its target price raised by Wells Fargo & Co from $525.00 to $590.00 in a report issued on Friday, The Fly reports. The brokerage currently has an overweight rating
The Global Biotechnology Reagents Market will grow by USD 37.87 bn during 2020-2024
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Purchased by Sumitomo Mitsui Trust Holdings Inc.
08:10am, Monday, 03'rd Aug 2020
Sumitomo Mitsui Trust Holdings Inc. boosted its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) by 0.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exch
The Global DNA Sequencing Market will grow by USD 12.5 bn during 2020-2024
Nissay Asset Management Corp Japan ADV Has $1.06 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)
07:42am, Sunday, 02'nd Aug 2020
Nissay Asset Management Corp Japan ADV raised its position in Bio-Rad Laboratories, Inc. (NYSE:BIO) by 11.6% during the second quarter, according to the company in its most recent disclosure with the
Bio-Rad Laboratories (NYSE:BIO) Reaches New 52-Week High on Earnings Beat
09:52am, Saturday, 01'st Aug 2020
Bio-Rad Laboratories, Inc. (NYSE:BIO) shares reached a new 52-week high on Thursday following a stronger than expected earnings report. The stock traded as high as $539.00 and last traded at $534.74,
Bio-Rad Laboratories Inc (BIO) (BIO.B) Q2 2020 Earnings Call Transcript
12:33am, Saturday, 01'st Aug 2020
Ladies and gentlemen, thank you for standing by, and welcome to the Q2 2020 Bio-Rad Laboratories, Inc. Earnings Conference Call. Before we begin our review, I would like to caution everyone that we w
Bio-Rad (BIO) Q2 Earnings Beat Estimates, Gross Margin Rises
02:36pm, Friday, 31'st Jul 2020
Bio-Rad's (BIO) second-quarter 2020 results reflect strong performance by the Life Sciences segment, boosted by coronavirus-led increased testing demand.
The Daily Biotech Pulse: Sanofi-GSK Land $2.1B Funding For Coronavirus Vaccine, D-Day For GW Pharma, FDA Nod For Roche
12:00am, Friday, 31'st Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 30)
Achieve Life Sciences Inc (NASDAQ: ACHV)
Annexon Inc (NASDAQ: ANNX) (IPOed July 24)
Atossa Therapeutics...
Sign In
Buy BIO